| Product NDC: | 0574-0113 |
| Proprietary Name: | Calcium Acetate |
| Non Proprietary Name: | CALCIUM ACETATE |
| Active Ingredient(s): | 667 mg/1 & nbsp; CALCIUM ACETATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0574-0113 |
| Labeler Name: | Paddock Laboratories, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091561 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110913 |
| Package NDC: | 0574-0113-02 |
| Package Description: | 200 TABLET in 1 BOTTLE (0574-0113-02) |
| NDC Code | 0574-0113-02 |
| Proprietary Name | Calcium Acetate |
| Package Description | 200 TABLET in 1 BOTTLE (0574-0113-02) |
| Product NDC | 0574-0113 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CALCIUM ACETATE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110913 |
| Marketing Category Name | ANDA |
| Labeler Name | Paddock Laboratories, LLC |
| Substance Name | CALCIUM ACETATE |
| Strength Number | 667 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |